BlackRock Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
BFA
BIT
BlackRock Group's HAE Position: Q4 2016 in Review
BlackRock Group increased its Haemonetics (HAE) stake by 47% in Q4 2016, buying an estimated $1.26M and bringing the position to 104,738 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1286.
BlackRock Group first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.
- BlackRock Group held 104,738 shares of Haemonetics worth $4.21M as of Q4 2016.
- BlackRock Group bought 33,500 Haemonetics shares in Q4 2016, an estimated $1.26M.
- Haemonetics made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1286 holding.
- BlackRock Group first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
- 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.